28189277|t|Improved Outcomes With the Evolution of a Neoadjuvant Chemotherapy Approach to Right Heart Sarcoma
28189277|a|Right-side heart sarcomas tend to be bulky, infiltrative, and difficult to treat. We have previously examined our outcomes with right heart sarcomas. Surgical resection with R0 margins showed better survival than positive margins but in only one third of cases could R0 status be achieved. The hypothesis for this study was that preoperative neoadjuvant chemotherapy would shrink the tumor margins and allow an increase in R0 resection, and hence, better survival. Review of our cardiac tumor database from 1990 to 2015 yielded 133 primary cardiac sarcoma cases. Of these, we identified 44 patients with primary right-side heart sarcomas. Prospective database and retrospective data collection and clinical outcomes were evaluated for all 44 patients. Primary outcomes included 30-day mortality and morbidity and long-term survival. We used univariate and multivariate analyses to identify independent predictors of overall survival. There were 27 male and 17 female patients with a mean age of 41 Â± 12.7 years (range, 15 to 67). Seventy-three percent of the patients (32 of 44) received neoadjuvant chemotherapy. The most common tumor histology was angiosarcoma in 30 of 44 (68%). Thirty-day mortality was 4.5%, and statistically similar between the two groups. The median survival of patients who had R0 resection was 53.5 months compared with 9.5 months for R1. Neoadjuvant chemotherapy led to a doubling of survival (20 versus 9.5 months). Neoadjuvant chemotherapy followed by radical surgery is a safe and effective strategy in patients with primary right-side heart sarcoma. This multimodality treatment enhances resectability (R0 resection) that translates into improved patient survival.
28189277	0	8	Improved	T033	C0184511
28189277	42	75	Neoadjuvant Chemotherapy Approach	T061	C4272610
28189277	79	98	Right Heart Sarcoma	T191	C0238152
28189277	99	124	Right-side heart sarcomas	T191	C0238152
28189277	174	179	treat	T061	C0087111
28189277	227	247	right heart sarcomas	T191	C0238152
28189277	249	267	Surgical resection	T061	C0015252
28189277	273	283	R0 margins	T033	C1709157
28189277	298	306	survival	T052	C0038952
28189277	312	328	positive margins	T033	C1709603
28189277	366	375	R0 status	T033	C1709157
28189277	428	440	preoperative	T079	C0445204
28189277	441	465	neoadjuvant chemotherapy	T061	C4272610
28189277	483	496	tumor margins	T201	C1269795
28189277	522	534	R0 resection	T061	C0015252
28189277	554	562	survival	T052	C0038952
28189277	578	591	cardiac tumor	T191	C0018809
28189277	592	600	database	T170	C0242356
28189277	631	654	primary cardiac sarcoma	UnknownType	C0518971
28189277	689	697	patients	T101	C0030705
28189277	711	736	right-side heart sarcomas	T191	C0238152
28189277	738	758	Prospective database	T170	C0242356
28189277	763	792	retrospective data collection	T062	C0035363
28189277	797	814	clinical outcomes	T080	C0085415
28189277	820	829	evaluated	T058	C0220825
28189277	841	849	patients	T101	C0030705
28189277	884	893	mortality	T081	C0205848
28189277	898	907	morbidity	T081	C0026538
28189277	912	921	long-term	T079	C0443252
28189277	922	930	survival	T052	C0038952
28189277	940	950	univariate	T062	C0683962
28189277	955	976	multivariate analyses	T081	C0026777
28189277	1023	1031	survival	T052	C0038952
28189277	1047	1051	male	T032	C0086582
28189277	1059	1065	female	T032	C0086287
28189277	1066	1074	patients	T101	C0030705
28189277	1158	1166	patients	T101	C0030705
28189277	1187	1211	neoadjuvant chemotherapy	T061	C4272610
28189277	1229	1234	tumor	T191	C0027651
28189277	1235	1244	histology	T091	C0019638
28189277	1249	1261	angiosarcoma	T191	C1261473
28189277	1292	1301	mortality	T081	C0205848
28189277	1373	1381	survival	T052	C0038952
28189277	1385	1393	patients	T101	C0030705
28189277	1402	1414	R0 resection	T061	C0015252
28189277	1464	1488	Neoadjuvant chemotherapy	T061	C4272610
28189277	1498	1506	doubling	T052	C1705764
28189277	1510	1518	survival	T052	C0038952
28189277	1543	1567	Neoadjuvant chemotherapy	T061	C4272610
28189277	1580	1595	radical surgery	T061	C0543467
28189277	1632	1640	patients	T101	C0030705
28189277	1654	1678	right-side heart sarcoma	T191	C0238152
28189277	1685	1708	multimodality treatment	T061	C0009429
28189277	1718	1731	resectability	T061	C0015252
28189277	1733	1745	R0 resection	T061	C0015252
28189277	1768	1776	improved	T033	C0184511
28189277	1777	1784	patient	T101	C0030705
28189277	1785	1793	survival	T052	C0038952